We are live on ! Find out more
APMC

Alta Partners Management Company Portfolio holdings

AUM $127M
1-Year Est. Return 230.85%
This Fund
S&P 500
This Quarter Est. Return
-32.54%
1 Year Est. Return
+230.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$63.4M
AUM Growth
Cap. Flow
+$80.6M
Cap. Flow %
127.12%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
TYRA icon
Tyra Biosciences
TYRA
+$74M
2
VIR icon
Vir Biotechnology
VIR
+$3.86M
3
ALLK
Allakos
ALLK
+$2.67M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYRA icon
1
Tyra Biosciences
TYRA
$1.56B
$56.7M 89.47%
+4,080,296
New +$74M
VIR icon
2
Vir Biotechnology
VIR
$1.87B
$3.59M 5.67%
+489,485
New +$3.86M
ALLK
3
DELISTED
Allakos
ALLK
$3.08M 4.86%
+2,546,147
New +$2.67M

Similar funds

Alta Partners Management Company's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Alta Partners Management Company, which disclosed 3 positions worth $63.4M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Tyra Biosciences: 4,080,296 shares worth $56.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Alta Partners Management Company's largest Q4 2024 buy was Tyra Biosciences: 4,080,296 shares worth $56.7M.
  • Alta Partners Management Company's ten largest holdings make up 100% of its $63.4M portfolio in Q4 2024.
  • Alta Partners Management Company disclosed 3 positions in Q4 2024, its first 13F filing on record.

Based on Alta Partners Management Company's 13F filing for Q4 2024, filed 5 Feb 2025.